Test Price
2,800 AED✅ Home Collection Available
NEK8 Gene Nephronophthisis Type 9 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
The NEK8 Gene Nephronophthisis Type 9 NGS Test is a targeted next‑generation sequencing analysis with a diagnostic accuracy of 99.9%. Priced at 2,800 AED, the test provides comprehensive detection of pathogenic variants in the NEK8 gene, the definitive cause of autosomal recessive nephronophthisis type 9. Turnaround time is 3–4 weeks from sample receipt. The service includes VIP mobile phlebotomy & temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM. A complimentary telephonic consultation with a clinical geneticist is included upon result delivery. Insurance pre‑approval can be verified instantly via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The NEK8 Gene Nephronophthisis Type 9 NGS Test employs next‑generation sequencing (NGS) to analyze the entire coding region and splice sites of the NEK8 gene. It detects single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variations (CNVs) with a sensitivity exceeding 99%. This molecular diagnosis confirms nephronophthisis type 9, facilitating targeted management, family screening, and genetic counselling.
| Feature | Our Test – NEK8 NGS | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) – full gene analysis | Conventional Sanger – single‑variant or exon‑by‑exon |
| Variant Detection | >99% sensitivity for SNVs, indels, CNVs | ~95% for known hot‑spot mutations only |
| Turn‑around Time | 3–4 weeks | 4–6 weeks |
| Clinical Utility | Comprehensive – diagnosis, carrier testing, family screening | Limited – often requires multiple sequential tests |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Genetics, I emphasise that this advanced genetic test provides crucial molecular insight into nephronophthisis type 9. However, it must always be interpreted alongside renal imaging, biochemical markers, and a detailed family history. The results empower tailored management and genetic counselling, but they do not replace regular nephrology follow‑up. I advise every patient to review the findings with their treating nephrologist before making any health decisions.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Note on Medication & Clinical Decisions
Important: Do not discontinue or alter any prescribed medication, dietary regimen, or treatment plan based solely on genetic test results. This test is a diagnostic aid and must be used in conjunction with a full clinical evaluation by your physician. Always consult your treating doctor before making any changes to your health management.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: This test is not indicated for asymptomatic individuals without a personal or family history of cystic kidney disease. Minors require legal guardian consent strictly in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability. Prior genetic counselling is mandatory before testing.
- Red Flags (Seek Emergency Care): Sudden absence of urine output, severe flank or abdominal pain, signs of acute kidney injury (nausea, confusion, swelling), or severe electrolyte imbalance (muscle cramps, arrhythmia). These symptoms require immediate hospital evaluation, not just genetic testing.
Patient FAQ & Clinical Guidance
1. What does the NEK8 test detect and who should consider it?
The NEK8 NGS test identifies pathogenic mutations causing nephronophthisis type 9. It is recommended for patients with medullary kidney cysts, early‑onset renal failure, or a family history of inherited kidney disease. The test confirms the diagnosis at the molecular level and enables accurate genetic counselling for affected individuals and their families.
2. How is the sample collected, and how long do results take?
A peripheral blood sample is collected during a VIP mobile phlebotomy visit with temperature‑controlled cold‑chain logistics. Complete NGS results are delivered within 3 to 4 weeks after certified laboratory processing. You will receive a digital report with expert interpretation, and a telephonic consultation with a genetic counsellor is included.
3. Is this test covered by insurance in the UAE?
Many UAE insurers provide coverage for medically necessary genetic diagnostics. We offer instant pre‑approval verification via WhatsApp at +971 54 548 8731 before scheduling your appointment. Direct billing arrangements with major networks are available to minimise out‑of‑pocket costs.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates under DHA Facility License No. 1143 and complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data are handled with strict confidentiality and stored in encrypted systems. The laboratory is ISO 9001:2015 certified. Clinical testing and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | NEK8 Gene Nephronophthisis Type 9 NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Whole gene sequencing with CNV analysis |
| ICD-10-CM Code | Q61.5, Z13.71, Z84.81 |
| LOINC Code | 94475-1 |
| DHA Facility License & Lab Address | DHA License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians